Mesenchymal Stromal Cells and Rheumatic Disorders
Mesenchymal stromal cells have been the intense focus of in vitro studies and animal models of rheumatic and other diseases over more than a decade. Despite multiple plausible mechanisms of action and a plethora of positive in vivo animal studies, few randomized controlled clinical trials have demonstrated meaningful clinical benefit in any condition so far. [Immunol Lett] Abstract
Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.
SCIENCE NEWS
Ocata Therapeutics Announces New Pre-Clinical Data to Be Reported
Ocata Therapeutics, Inc. announced that data demonstrated potential therapeutic activity of a pluripotent stem cell-derived product for the treatment of autoimmune diseases such as lupus nephritis and Crohn’s disease using Ocata’s proprietary hemangio-derived mesenchymal cell platform. [Press release from Ocata Therapeutics, Inc. discussing research to be presented at the 11th International Congress on Systemic Lupus Erythematosus, Vienna]
Press Release
Recruit Top Talent:
Reach more than 60,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!